WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and...
Did you know?
WebIn August 2024, Old Cytocom, now a wholly owned subsidiary of the Company, entered into an employment agreement with Mr. Handley, who currently serves as the Chief Executive Officer of Old... WebMay 1, 2014 · ORLANDO, Fla., May 1, 2014. /PRNewswire/ -- TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or the "Company"), a biopharmaceutical company focused on the development, marketing and distribution of opioid-related immunotherapies, announced that its board of directors has approved a plan to spin off its wholly-owned subsidiary, …
WebJul 6, 2024 · On July 27, 2024, Cytocom, Inc., formerly known as Cleveland BioLabs, Inc. (the “Company” or “Cleveland BioLabs”), High Street Acquisition Corp., a Delaware … WebOct 21, 2024 · Cytocom, Inc. About Cytocom, Inc. Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and …
WebSep 1, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and … WebApr 12, 2024 · Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. Benzinga 95d.
WebFind company research, competitor information, contact details & financial data for Cytocom Subsidiary Inc. of Fort Collins, CO. Get the latest business insights from Dun & Bradstreet.
WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. husy tube cutter copperWeb63 Uas jobs available in Ashburn Farm, VA on Indeed.com. Apply to Program Manager, Intelligence Analyst, Information Systems Manager and more! huszar herranhofWebImQuest Pharmaceuticals was merged into Cytocom’s existing drug development operations, and ImQuest Biosceinces, the contract research organization (CRO), operates as wholly-owned, revenue-generating … huszar\\u0027s 12 lead ecg and interpretation pdfWebSep 28, 2024 · On June 24, 2024, Cytocom completed the acquisition of ImQuest Life Sciences, Inc. and its subsidiaries ("ImQuest") in accordance with the Agreement and Plan of Merger by and among Cytocom and ImQuest dated as of July 17, 2024, and gained control of ImQuest. husys consulting ltdWebAug 31, 2024 · Cytocom, Inc. emerged as a publicly-traded entity following the merger between the former Cleveland BioLabs and the formerly private Cytocom Inc., completed on July 27, 2024. “The new corporate name, Statera BioPharma and updated ticker symbol mark the latest event in a transformative year for the company,” said Michael K. Handley, … mary page marlowe ticketsWebContact Email [email protected]. Phone Number 1-888-629-4155. Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most … mary page michelWebAcquired By: Cytocom Subsidiary Inc. ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. husz on the web